Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Revenue

Dermapharm Holding SE had revenue of 305.80M EUR in the quarter ending March 31, 2026, with 1.13% growth. This brings the company's revenue in the last twelve months to 1.17B, down -1.36% year-over-year. In the year 2025, Dermapharm Holding SE had annual revenue of 1.16B, down -1.34%.

• Revenue (ttm): 1.17B
• Revenue Growth: -1.36%
• P/S Ratio: 1.75
• Revenue / Employee: 337.49K
• Employees: 3,503
• Market Cap: 2.07B

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.16B	-15.79M	-1.34%
Dec 31, 2024	1.18B	45.42M	4.00%
Dec 31, 2023	1.14B	110.58M	10.79%
Dec 31, 2022	1.02B	81.86M	8.68%
Dec 31, 2021	942.91M	149.08M	18.78%
Dec 31, 2020	793.83M	92.95M	13.26%
Dec 31, 2019	700.88M	128.46M	22.44%
Dec 31, 2018	572.42M	105.31M	22.54%
Dec 31, 2017	467.12M	22.64M	5.09%
Dec 31, 2016	444.48M	-	-

Data Source: Fiscal.ai Last updated: May 13, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 24, 2026

Data Sources Report a data error